ARQ 092 Free Base
Title | Journal |
---|---|
Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor. | Journal of medicinal chemistry 20160714 |
Targeting AKT1-E17K and the PI3K/AKT Pathway with an Allosteric AKT Inhibitor, ARQ 092. | PloS one 20150101 |
Repression of AKT signaling by ARQ 092 in cells and tissues from patients with Proteus syndrome. | Scientific reports 20150101 |
Schizophrenic inability to disattend from strong aspects of meaning. | Journal of abnormal psychology 19760201 |